218 related articles for article (PubMed ID: 32606665)
1. Formulation and Characterization of Sertaconazole Nitrate Mucoadhesive Liposomes for Vaginal Candidiasis.
Abdellatif MM; Khalil IA; Elakkad YE; Eliwa HA; Samir TM; Al-Mokaddem AK
Int J Nanomedicine; 2020; 15():4079-4090. PubMed ID: 32606665
[TBL] [Abstract][Full Text] [Related]
2. Ultra-deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative
Albash R; Elmahboub Y; Baraka K; Abdellatif MM; Alaa-Eldin AA
Drug Deliv; 2020 Dec; 27(1):1514-1523. PubMed ID: 33108907
[TBL] [Abstract][Full Text] [Related]
3. Sertaconazole: pharmacology of a gynecological antifungal agent.
Palacín C; Tarragó C; Ortiz JA
Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S37-46. PubMed ID: 11118563
[TBL] [Abstract][Full Text] [Related]
4. Sertaconazole in the treatment of mycoses: from dermatology to gynecology.
Torres J; Márquez M; Camps F
Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S3-20. PubMed ID: 11118560
[TBL] [Abstract][Full Text] [Related]
5. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
6. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the efficacity and speed of action of sertaconazole nitrate suppository and cream combined treatment for vulvovaginal candidiasis].
Quereux C; Gelas B; Chevallier T; Petit F; Micheletti MC
Gynecol Obstet Fertil; 2000 Mar; 28(3):238-44. PubMed ID: 10786405
[TBL] [Abstract][Full Text] [Related]
8. Vaginal Delivery of Benzydamine Hydrochloride through Liposomes Dispersed in Mucoadhesive Gels.
Tuğcu-Demiröz F
Chem Pharm Bull (Tokyo); 2017 Jul; 65(7):660-667. PubMed ID: 28442642
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
10. Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation.
Abdellatif MM; Khalil IA; Khalil MAF
Int J Pharm; 2017 Jul; 527(1-2):1-11. PubMed ID: 28522423
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories.
Dellenbach P; Thomas JL; Guerin V; Ochsenbein E; Contet-Audonneau N
Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S47-52. PubMed ID: 11118564
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis.
Tavakoli N; Taymouri S; Saeidi A; Akbari V
Pharm Dev Technol; 2019 Sep; 24(7):891-901. PubMed ID: 31062987
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect.
Jøraholmen MW; Vanić Z; Tho I; Skalko-Basnet N
Int J Pharm; 2014 Sep; 472(1-2):94-101. PubMed ID: 24928137
[TBL] [Abstract][Full Text] [Related]
14. [In vitro determination of the texture of 3 gynecologic antifungal agents: TX 15338 (Monazole, sertaconazole nitrate) and 2 related products].
Cros C; Chevallier T
Presse Med; 1998 Dec; 27(38):1955. PubMed ID: 9879318
[No Abstract] [Full Text] [Related]
15. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
Refai H; Hassan D; Abdelmonem R
Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of sertaconazole in experimental candidiasis in the mouse.
Palacin C; Sacristán A; Ortiz JA
Drugs Exp Clin Res; 1990; 16(9):469-73. PubMed ID: 2100249
[TBL] [Abstract][Full Text] [Related]
18. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.
Carrillo-Muñoz AJ; Tur-Tur C; Giusiano G; Marcos-Arias C; Eraso E; Jauregizar N; Quindós G
Expert Rev Anti Infect Ther; 2013 Apr; 11(4):347-58. PubMed ID: 23566144
[TBL] [Abstract][Full Text] [Related]
19. Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.
Takalkar D; Desai N
AAPS PharmSciTech; 2018 Apr; 19(3):1297-1307. PubMed ID: 29340981
[TBL] [Abstract][Full Text] [Related]
20. Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies.
Younes NF; Abdel-Halim SA; Elassasy AI
Int J Pharm; 2018 Dec; 553(1-2):386-397. PubMed ID: 30393167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
